Geistlich Fibro-Gide^® is a porcine, porous, resorbable and volume-stable collagen matrix, specifically designed for soft-tissue regeneration.¹ The collagen matrix is made of reconstituted collagen and undergoes smart chemical cross-linking to improve its volume stability while maintaining a good biocompatibility.^1-3 The porous network of Geistlich Fibro-Gide^® supports angiogenesis, formation of new connective tissue and stability of the collagen network in submerged healing.^2,3 In vivo animal models have shown good integration of Geistlich Fibro-Gide^® into the surrounding soft-tissue while maintaining stability.⁴

Geistlich Fibro-Gide^® is the alternative to autogenous connective tissue grafts (CTG), which are considered as the gold standard in regenerative soft-tissue procedures.^3,5,6 With Geistlich Fibro-Gide^® additional harvest site is avoided, patient morbidity is reduced.^3,7-9

Inspired by Nature, engineered by Geistlich

The collagen expertise of Geistlich has led to a tailor-made product meeting the clinical needs and providing therapeutic solutions in oral soft-tissue regeneration. More than 1,000 prototypes were developed and tested in order to get a product like Geistlich Fibro-Gide^®.¹¹

Geistlich Fibro-Gide^® is not yet available in Australia. Please contact your local Geistlich specialist on 1800 776 326 in Australia and 0800 776 326 in NZ to find out more. 

References 

1. Instructions for Use. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland. 
2. Thoma DS. et al. Clin Oral Implants Res. 2015 Mar; 26(3): 263–70.
3. Thoma DS. et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
4. Thoma DS. et al. Clin Oral Implants Res. 2012 Dec; 23(12): 1333–9.
5. Thoma DS. et al. Clin Oral Implants Res. 2009 Sep; 20 Suppl 4: 146–65.
6. Thoma DS. et al. J Clin Periodontol. 2014 Apr; 41 Suppl 15: S77–91.
7. Sanz M. et al. J Clin Periodontol 2009; 36(10): 868-76.
8. Del Pizzo M. et al. J Clin Periodontol. 2002 Sep; 29(9): 848–54.
9. Soileau KM. & Brannon RB. J Periodontol. 2006 Jul; 77(7): 1267–73.
10. Zeltner M. et al. J Clin Periodontol. 2017 Apr; 44(4): 446–453.
11. Data on file. Geistlich Pharma AG, Wolhusen, Switzerland.